BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 14660718)

  • 21. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
    Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
    Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.
    Horn J; Lock-Andersen J; Sjøstrand H; Loft A
    Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):887-92. PubMed ID: 16586078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staging of regional lymph nodes in melanoma patients by means of 99mTc-MIBI scintigraphy.
    Alonso O; Martínez M; Delgado L; De León A; De Boni D; Lago G; Garcés M; Fontes F; Espasandín J; Priario J
    J Nucl Med; 2003 Oct; 44(10):1561-5. PubMed ID: 14530467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of lymph node ultrasound and whole body
    Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ
    Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography scanning in malignant melanoma.
    Tyler DS; Onaitis M; Kherani A; Hata A; Nicholson E; Keogan M; Fisher S; Coleman E; Seigler HF
    Cancer; 2000 Sep; 89(5):1019-25. PubMed ID: 10964332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Planar coincidence scintigraphy and PET in staging malignant melanoma.
    Steinert HC; Voellmy DR; Trachsel C; Bicik I; Buck A; Huch RA; von Schulthess GK
    J Nucl Med; 1998 Nov; 39(11):1892-7. PubMed ID: 9829578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.
    Eckel F; Herrmann K; Schmidt S; Hillerer C; Wieder HA; Krause BJ; Schuster T; Langer R; Wester HJ; Schmid RM; Schwaiger M; Buck AK
    J Nucl Med; 2009 Sep; 50(9):1441-7. PubMed ID: 19690030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS; Francis IR; Zasadny KR; Wahl RL
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
    Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer.
    Yamamoto Y; Nishiyama Y; Kimura N; Ishikawa S; Okuda M; Bandoh S; Kanaji N; Asakura M; Ohkawa M
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):236-45. PubMed ID: 17909790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
    Fuster D; Chiang S; Johnson G; Schuchter LM; Zhuang H; Alavi A
    J Nucl Med; 2004 Aug; 45(8):1323-7. PubMed ID: 15299056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG PET in early stage cutaneous malignant melanoma.
    McIvor J; Siew T; Campbell A; McCarthy M
    J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography in patients with breast cancer using (18)F-3'-deoxy-3'-fluoro-l-thymidine ((18)F-FLT)-a pilot study.
    Been LB; Elsinga PH; de Vries J; Cobben DC; Jager PL; Hoekstra HJ; Suurmeijer AJ
    Eur J Surg Oncol; 2006 Feb; 32(1):39-43. PubMed ID: 16269226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
    Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
    J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18F]FLT PET for diagnosis and staging of thoracic tumours.
    Dittmann H; Dohmen BM; Paulsen F; Eichhorn K; Eschmann SM; Horger M; Wehrmann M; Machulla HJ; Bares R
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1407-12. PubMed ID: 12898201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer.
    Francis DL; Visvikis D; Costa DC; Arulampalam TH; Townsend C; Luthra SK; Taylor I; Ell PJ
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):988-94. PubMed ID: 12739071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
    Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
    Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact.
    Stas M; Stroobants S; Dupont P; Gysen M; Hoe LV; Garmyn M; Mortelmans L; Wever ID
    Melanoma Res; 2002 Oct; 12(5):479-90. PubMed ID: 12394190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making.
    Gulec SA; Faries MB; Lee CC; Kirgan D; Glass C; Morton DL; Essner R
    Clin Nucl Med; 2003 Dec; 28(12):961-5. PubMed ID: 14663316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose.
    Böni R; Böni RA; Steinert H; Burg G; Buck A; Marincek B; Berthold T; Dummer R; Voellmy D; Ballmer B
    Br J Dermatol; 1995 Apr; 132(4):556-62. PubMed ID: 7748746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.